Hospital admission for hyperemesis gravidarum in women at increased risk of spontaneous preterm birth by Kleine, I et al.
Birth. 2017;1–6. wileyonlinelibrary.com/journal/birt  |  1
Received: 26 February 2017 | Revised: 28 June 2017 | Accepted: 28 June 2017
DOI: 10.1111/birt.12303
O R I G I N A L  A R T I C L E
Hospital admission for hyperemesis gravidarum in women at 
increased risk of spontaneous preterm birth
Ira Kleine MA, MBBS1 | Ana Da Silva MBBS, MSc2 | Wafaa Ahmed MBBCh, MSc3 |  
Frida Forya BSc, MSc3 | Sara M. Whitten MBBS, CLTechHE1,2,3 | Anna L. David MBChB, 
PhD2,3 | Catherine P. James MBBS, PhD2,3
1UCL Medical School, London, UK
2Fetal Medicine Unit, University College 
London Hospitals NHS Foundation Trust, 
London, UK
3UCL Institute for Women’s Health, 
London, UK
Correspondence
Catherine P. James, UCL Institute for 
Women’s Health, 86-96 Chenies Mews, 
London, WC1E 6HX, UK.
Email: catherine.james@ucl.ac.uk
Funding information
Wellbeing of Women and The 
Wellcome Trust, Grant/Award Number: 
WT097228MA; Department of Health 
NIHR Biomedical Research Centre
Abstract
Background: Progesterone administration prevents spontaneous preterm birth (sPTB) 
in women at increased risk. Progesterone concentration is lower in women with sub-
sequent sPTB. Conversely, high concentrations of progesterone are implicated in the 
pathogenesis of hyperemesis gravidarum (HG). We hypothesized that women at in-
creased risk of sPTB or spontaneous late miscarriage would be less likely to have a 
diagnosis of HG. To explore this hypothesis, we compared the incidence of HG in 
women at increased risk of sPTB and women with no identifiable risk factors.
Methods: Women at increased risk of sPTB were identified from a specialist Preterm 
Birth Clinic (PTBC) database where criteria for PTBC attendance are previous cervi-
cal surgery, previous sPTB <34 weeks, previous spontaneous late miscarriage, inci-
dental sonographic cervical shortening, and uterine anomaly. Hospital antenatal 
booking and coding records for the same time period were examined to identify HG 
admissions. Women with multiple gestations, trophoblastic disease, or pre- existing 
abnormal thyroid function were excluded. The incidence of HG among PTBC 
(n=394) and non- PTBC attendees (n=4762) was calculated.
Results: The incidence of HG was lower in women at increased risk of sPTB (1.52%, 
n=6) compared with women with no identifiable risk factor for sPTB (3.33%, n=159; 
P=.049).
Conclusion: Hospital admission for HG is reduced in women with risk factors for 
sPTB compared with those without risk factors. Exploration of the pathogenesis of 
HG may improve understanding of the mechanisms underlying sPTB.
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1 |  BACKGROUND
Altered progesterone concentration is implicated in the 
pathogenesis of both hyperemesis gravidarum (HG) and 
spontaneous preterm birth (sPTB). Antenatal administration 
of progesterone prevents sPTB in women at increased risk.1 
Low concentration of salivary progesterone was found to 
be associated with recurrent sPTB in a retrospective cohort 
of women at increased risk of sPTB,2 an observation that 
has been supported by more recent prospectively collected 
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data.3–5 Historically HG is more common in multiple preg-
nancy where progesterone concentrations are higher. A recent 
meta- analysis6 identified two studies showing an association 
between high serum progesterone concentration and HG.7,8 
It seems plausible, therefore, that HG and sPTB are the clin-
ical manifestations of opposite extremes of a biochemical 
spectrum, although the complexity of the fetal- placental unit 
makes identifying a single factor and its role challenging.
Studies investigating the relationship between HG and 
sPTB have thus far been contradictory; some indicate that 
HG is a risk factor for sPTB,9,10 while others state that 
there is either no effect,11 or that a diagnosis of HG may be 
protective.12 Stratification for risk of sPTB generally uses 
the past obstetric and surgical history. In particular, women 
who have experienced at least one sPTB or spontaneous late 
miscarriage are known to be at increased risk of recurrent 
sPTB.13 Other risk factors for sPTB and spontaneous late 
miscarriage include: cervical surgery such as large loop ex-
cision of the transformation zone, or cone biopsy14; uterine 
anomaly15; incidental finding of a short cervical length16; and 
uterine surgery.17
We hypothesized that women at increased risk of sPTB 
or spontaneous late miscarriage would be less likely to have 
a diagnosis of HG. While the term HG is used relatively 
loosely in clinical practice, the NICE guidance defines HG 
as “prolonged and severe nausea and vomiting, dehydration, 
electrolyte imbalance, ketosis, the need for admission to hos-
pital, and body weight loss of more than 5% of pre- pregnancy 
weight.”18 We examined our hypothesis by comparing the in-
cidence of HG as defined above in women at increased risk of 
sPTB with those women with no risk factors for sPTB iden-
tifiable at booking.
2 |  METHODS
Electronic records for all women booking at University 
College London Hospital (UCLH) between April 
2012 and January 2014 were identified by the Medical 
Coding and Information Systems departments. 
Women booking in this period who were referred to 
the Preterm Birth Clinic (PTBC) were identified from 
the prospectively collected PTBC database; Table 1 
describes the referral criteria. These women were sub-
sequently considered separately from the total ante-
natal booking population, thus creating two groups: 
(1) women booking between April 2012 and January 2014 
identified as being at increased risk of sPTB, n=394 (PTBC 
cohort), and (2) women booking in the same time period 
with no identifiable risk factors, n=4762 (non- PTBC co-
hort). Women with multiple gestations, trophoblastic dis-
ease, and abnormal thyroid function were excluded.19 We 
examined the casenotes and PTBC database for evidence 
of progesterone treatment in the first and second trimes-
ters; these women were subsequently excluded (Figure 1).
Hospital admissions for HG were retrieved from the 
Medical Coding using ICD- 10 codes O21.0 (mild HG) and 
O21.1 (HG with metabolic disturbance); n=6 for women at-
tending the PTBC and n=159 for the women with no risk fac-
tor for sPTB. Figure 1 shows a diagrammatic representation 
of the inclusion process.
VassarStats (http://vassarstats.net/) was used to calculate 
the significance of the difference between the proportions 
of women with HG in the two groups (Table 2). The need 
for institution ethical review board approval was waived by 
the NHS Health Research Authority which deemed that the 
study was not research, since this was analysis of routinely 
collected local hospital patient data.
3 |  RESULTS
Eighteen women who attended the PTBC during the study 
period were treated with progesterone (median gestational 
age: 12 weeks [2 + 0 to 20 + 5 weeks]; gestational data 
unavailable for three women); none were admitted with HG. 
Fourteen of the 394 women included in the study took part in 
the OPPTIMUM randomized control trial, which investigates 
the use of progesterone in preventing sPTB, taking either pro-
gesterone or placebo after 20 weeks of gestation20; none of 
these women were admitted with HG, although the timing of 
this progesterone use anyhow precludes it from contributing 
to first- trimester HG presentations. Forty out of 416 women 
who attended the PTBC had a cervical cerclage procedure; 
none were admitted with HG. Treatment with progesterone 
and/or cerclage is not offered to non- PTBC women.
Six out of 412 women (1.46%) in the PTBC cohort were 
admitted with HG, compared with 159 out of 4762 women 
(3.33%) in the non- PTBC cohort (z ratio 2.086, P = .037). 
When excluding women treated with progesterone from anal-
ysis, the difference in proportions remained significant (6 of 
the remaining 394 PTBC cohort women [1.52%] were admit-
ted with HG; z = 1.97, P = .049; Table 2).
T A B L E  1  Reasons for referral to the PTBC among the cohort of 
women seen in PTBC at UCLH between April 2012 and January 2014
Large Loop Excision of the Transformation Zone (LLETZ) 165
Cervical cone biopsy 46
Previous sPTB 87
Previous spontaneous mid- trimester/late miscarriage 51
Incidental finding of a short cervical length 12
Uterine anomaly 25
Ehlers Danlos Syndrome/hypermobility 6
Uterine surgery 2
Total 394
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F I G U R E  1  Case identification process and pregnancy outcomes in women at increased risk of sPTB (PTBC cohort) and those not at 
increased risk (non- PTBC cohort) in a retrospective cohort study at UCLH between April 2012 and January 2014. Records were identified by the 
PTBC database and the Medical Coding and Information Systems departments; the final groups were defined after applying the exclusion criteria. 
The overall sPTB rate for women attending the PTBC was 11.4% (n=45). Pregnancy outcome data were available for 81.8% (n=130) of women not 
attending the PTBC; of this group the overall sPTB rate was 7.7%. IUD, intrauterine death; TOP, termination of pregnancy
4 |   KLEINE Et aL.
4 |  DISCUSSION
Among the antenatal population of UCLH, we observed that 
the incidence of HG, as defined by ICD- 10 diagnosis, was 
significantly lower in women identified at booking to be at 
increased risk of sPTB and referred to the PTBC, compared 
with those women not identified to be at increased risk of 
sPTB. These data support our hypothesis that women at in-
creased risk of sPTB because of their past obstetric history, 
or other maternal factors, are less likely to suffer HG in their 
pregnancy.
These data are in keeping with the work of Vandraas et al., 
who identified an inverse association between HG and sPTB 
(<32 weeks) when analyzing the Medical Birth Registry of 
Norway.12 In contrast, previous studies show correlations 
between HG and an increased risk of PTB,9,10,21 which may 
be explained by their heterogeneous definitions of HG12 and 
their inclusion of all PTB, both iatrogenic and spontaneous. 
Protracted HG can be associated with fetal growth restriction 
leading to iatrogenic PTB.22,23
The results of this study are in keeping with the concept 
that women who deliver spontaneously preterm have an al-
tered hormonal response to pregnancy, which may in turn be 
associated with abnormal placentation. The known associa-
tion between HG persisting into the second trimester and later 
placental dysfunction disorders, such as pre- eclampsia and 
placental abruption,24 supports this hypothesis. Moreover, a 
recent meta- analysis6 identified two studies showing an as-
sociation between high serum progesterone concentration 
and HG.7,8 Thus, although these studies were done in inde-
pendent cohorts, it could be hypothesized that higher proges-
terone concentrations confer a lower risk of sPTB. The lack 
of association between progesterone concentration and HG 
described in the third study25 identified by Niemeijer et al. 
may be explained by their categorization of women’s sever-
ity of nausea and vomiting according to patient- completed 
questionnaires, rather than the more objective NICE standard 
definition for HG.5
Additional work is needed to explore the difference in ad-
mission rates for HG between women with risk factors for 
sPTB and those without these risk factors. A prospective 
study comparing serum or salivary progesterone levels and 
pregnancy outcomes in the two groups may be useful in this 
respect. 
5 |  STRENGTHS AND  
LIMITATIONS
This analysis is limited by the sample sizes of the sub-
groups within the PTB HG group; these are insufficient to 
allow subgroup analysis, which prevents us from studying 
whether there is a link between HG and gestational age 
at delivery. Furthermore, complete outcome data are not 
available for non- PTBC women not admitted with HG; it 
is therefore impossible to infer what proportion of the non-
PTBC cohort actually delivered spontaneously preterm. 
Although this limits the conclusions that can reasonably 
be drawn from this study, it does not compromise the ob-
servation that women with risk factors for sPTB are less 
likely to be admitted for HG than women without these 
risk factors.
Notably, the incidence of HG in the non- PTBC cohort 
(3.33%) is higher than figures quoted elsewhere: 0.8%,12 or 
0.5- 2%.18 This is likely to be because of the variability in 
coding definitions used in the studies to calculate HG inci-
dence. Similarly, the rate of termination of pregnancy in our 
cohort was higher than the age- standardized termination rate 
for England and Wales (1.59% in 2013)26 but is lower than 
that reported among women hospitalized with HG in a large 
multi- center study (10.6%).27
We excluded women who had been treated with proges-
terone from the analysis on the grounds that this may have 
altered their risk of HG. The PTBC practice followed the 
RCOG statement at the time: to only prescribe progester-
one prophylaxis for preterm birth within the confines of a 
clinical trial. The PTBC was recruiting to the OPPTIMUM 
randomized controlled trial.20 However, some women were 
referred having been prescribed progesterone by medi-
cal practitioners outside the PTBC. The small number of 
women who took prophylactic progesterone (n=18) there-
fore excluded those most at risk of sPTB. The decision to 
exclude these women may have introduced a degree of se-
lection bias; however as the residual PTBC group was con-
sequently composed of women with a lower risk of sPTB it 
is likely that the effect of this selection would be to reduce 
any difference in HG admissions between the two groups. 
We are therefore confident that the difference observed is 
not the result of selection bias.
Finally, although we excluded women with certain key in-
dividual risk factors for HG—including multiple pregnancy, 
presence of trophoblastic disease, and thyroid disease19—
others were not identified in this study and thus, the follow-
ing confounding factors were not considered: age; ethnicity; 
T A B L E  2  Incidence of HG in the women at increased risk of 
sPTB (PTBC cohort) and those not at increased risk (non- PTBC 
cohort) in a retrospective cohort study at UCLH between April 2012 
and January 2014
Incidence of HG in 
PTBC cohort
Incidence of HG in 
non- PTBC cohort
P value 
(z ratio)
1.52% 
(6/394)
3.33% 
(159/4762)
0.049 
(1.97)
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parity; sex of fetus; and family history of HG. Moreover, this 
analysis was not able to identify antenatal progesterone use 
in the non- PTBC cohort. This necessitates some caution with 
the conclusions drawn.
6 |  CONCLUSION
In summary, this study found that hospital admission for HG 
in women at increased risk of sPTB was reduced compared 
with women with no identifiable risk factors for sPTB. This 
supports our hypothesis that HG and sPTB are clinical mani-
festations of opposite extremes of a biochemical spectrum, 
and suggests that further exploration of the pathogenesis of 
HG may facilitate our understanding of the mechanisms un-
derlying sPTB.
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